Introduction

Digital biomarkers are defined as objective, quantifiable physiological and behavioural data that is collected and measured by means of digital devices such as portables, wearables, implantables or digestibles. The data collected is typically used to explain, influence and/or predict health-related outcomes. Digital biomarkers also represent an opportunity to capture clinically meaningful, objective data. *1,3

eBiomarkers can provide objective measurements to base and support diagnosis, prognosis, and measure therapeutic outcomes.

• A strong, established, scientific foundation of the applications of digital tools and technologies for healthcare/public health is paramount.  

• We believe the domain could act as a library of every eBiomarker ever discovered, researched and implemented in areas of healthcare and public health; and thus could act as a data sharing platform for researchers to share findings. 

• This domain could be used to attract local and international Industry giants, emerging digital start-ups/platforms or research governing bodies but its broad representation makes it applicable in other fields too such as trading and e-commerce. 

• The domain itself is short, simple and memorable. 

• Mobile Health Apps and Sensors.

• Patient Monitoring Platforms.

• Artificial Intelligence (AI), Radiomics (Imaging markers), Proteomics (Protein markers eg. from tissue, bloods etc), Genomics (Gene markers eg. from DNA, RNA etc).

• Please refer Rockhealth*1 page where the applications, challenges and importance of eBiomarkers are brilliantly explained.

1)  https://rockhealth.com/reports/theemerging-influence-of-digital-biomarkerson-healthcare/

2) https://www.karger.com/Journal/Details/271954

3) https://www.roche.com/about/priorities/personalised_healthcare/digitalbiomarkers.htm